Osteoporosis and Deafness neurosensory
Summary:
Deafness neurosensory is found among people with Osteoporosis, especially for people who are female, 60+ old.
The study analyzes which people have Deafness neurosensory with Osteoporosis. It is created by eHealthMe based on reports of 284 people who have Osteoporosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
284 people who have Osteoporosis and Deafness Neurosensory are studied.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 2,571 drugs and 1,861 conditions by eHealthMe.
What is Deafness neurosensory?
Deafness neurosensory is found to be associated with 1,411 drugs and 862 conditions by eHealthMe.
Number of Deafness neurosensory in Osteoporosis reports submitted per year:
Gender of people who have Osteoporosis and experienced Deafness neurosensory *:
Age of people who have Osteoporosis and experienced Deafness neurosensory *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Deafness neurosensory?
Check whether Deafness neurosensory is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Related studies
Treatments, associated drugs and conditions:
- Osteoporosis (269,810 reports)
- Deafness neurosensory (4,111 reports)
COVID vaccines that are related to Deafness neurosensory:
- Deafness neurosensory in Moderna COVID Vaccine
- Deafness neurosensory in Pfizer BioNTech Covid Vaccine
- Deafness neurosensory in Johnson and Johnson Covid Vaccine
Common drugs associated with Deafness neurosensory:
- Prednisone: 436 reports
- Methotrexate: 435 reports
- Tylenol: 379 reports
- Enbrel: 344 reports
- Gabapentin: 344 reports
- Celebrex: 341 reports
- Oxycontin: 318 reports
- Fosamax: 312 reports
- Nasonex: 307 reports
- Sulfasalazine: 301 reports
All the drugs that are associated with Deafness neurosensory:
- Deafness neurosensory (1,411 drugs)
Common conditions associated with Deafness neurosensory:
- Rheumatoid arthritis: 432 reports
- Osteoporosis: 284 reports
- Pain: 261 reports
- Arthritis: 248 reports
- High blood pressure: 161 reports
- Sleep disorder: 148 reports
All the conditions that are associated with Deafness neurosensory:
- Deafness neurosensory (862 conditions)
How the study uses the data?
The study is based on Deafness neurosensory and Osteoporosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hydroxychloroquine Sulfate and Temazepam drug interaction - now
- Adderall Xr 15 and High Blood Pressure - 7 seconds ago
- Alprostadil and Nexium drug interaction - 9 seconds ago
- Vaniqa and Arrhythmias - 10 seconds ago
- Calcipotriene and Hyperkeratosis - 11 seconds ago
- Intervertebral Disc Degeneration and Thrombocytopenia Aggravated - 12 seconds ago
- Leflunomide and Postoperative Thrombosis - 14 seconds ago
- Otezla and Imuran drug interaction - 19 seconds ago
- Tofacitinib Citrate and Arthropathy - 28 seconds ago
- Furosemide and Pleural Disorder - 39 seconds ago